Technology Venture Partners Healthcare News

This is selected healthcare news for Technology Venture Partners, which is filed under Capital Firms. There are 10 news items for this page. A press release filter page is also available for Technology Venture Partners.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source
10/19/2021 RedShift BioAnalytics Closes $20M Series E Funding Led by Illumina Ventures | Financial Buzz
... E Preferred Stock financing. The $20 million financing was led by Illumina Ventures and joined by all of the company's current major investors, including Technology Venture Partners and Waters Corporation. Proceeds of the financing will be used to fund additional commercial expansion, continued technology innovation, and execution of its ...
financialbuzz.com
10/18/2021 RedShift BioAnalytics Closes $20M Series E Funding Led by Illumina Ventures
... E Preferred Stock financing. The $20 million financing was led by Illumina Ventures and joined by all of the company's current major investors, including Technology Venture Partners and Waters Corporation. Proceeds of the financing will be used to fund additional commercial expansion, continued technology innovation, and execution of its ...
Yahoo News
10/18/2021 RedShift BioAnalytics Closes $20M Series E Funding Led by Illumina Ventures | Business Wire
... E Preferred Stock financing. The $20 million financing was led by Illumina Ventures and joined by all of the company's current major investors, including Technology Venture Partners and Waters Corporation. Proceeds of the financing will be used to fund additional commercial expansion, continued technology innovation, and execution of its ...
Business Wire
10/18/2021 RedShift BioAnalytics Closes $20M Series E Funding Led by Illumina Ventures
... E Preferred Stock financing. The $20 million financing was led by Illumina Ventures and joined by all of the company's current major investors, including Technology Venture Partners and Waters Corporation. Proceeds of the financing will be ...
Business Wire
1/13/2020 Given market demand, binx health announces launch of pre-order program for its first-of-kind rapid, molecular point-of-care platform
... point-of-care and at-home offerings. binx health's investors include financial investors Johnson & Johnson Innovation, Novartis Venture Fund, LSP, BB Biotech, RMI Investments and Technology Venture Partners and strategic investors Consort Medical (whose wholly owned subsidiary Bespak is the manufacturer of the company's low-cost, proprietary multiplex cartridges) and ...
PR Newswire
11/19/2019 binx health To Present At The Canaccord Genuity Medical Technology And Diagnostics Forum
... point-of-care and at-home menus. binx health's investors include financial investors Johnson & Johnson Innovation, Novartis Venture Fund, LSP, BB Biotech, RMI Investments and Technology Venture Partners and strategic investors Consort Medical (whose wholly owned subsidiary Bespak is the manufacturer of the company's low-cost, proprietary multiplex cartridges) and ...
PR Newswire
8/12/2019 binx health Receives FDA 510(k) Clearance For Rapid Point Of Care Platform For Women’s Health
... point-of-care and at-home offerings. binx health's investors include financial investors Johnson & Johnson Innovation, Novartis Venture Fund, LSP, BB Biotech, RMI Investments and Technology Venture Partners and strategic investors Consort Medical (whose wholly owned subsidiary Bespak is the manufacturer of the company's low-cost, proprietary multiplex cartridges) and ...
PR Newswire
6/18/2019 Symetrica secures £3m in growth funding to support further expansion in the US - BQLive
... round was co-led by Parkwalk, the UK's most active investor in university spin-outs, and Nesta and included follow on investments from Albion Investments, Technology Venture Partners and Tennants Ventures. Symetrica provides a range of detectors from handheld devices to mobile solutions and portal monitors, which are used by ...
bqlive.co.uk
6/11/2019 binx health Appoints Healthcare Industry Veteran Gail Marcus to Board of Directors
... care and at home offerings. binx health's investors include financial investors, Johnson & Johnson Innovation, Novartis Venture Fund, LSP Venture Capital, BB Biotech, RMI Investments and Technology Venture Partners and strategic investors, Consort Medical (whose wholly owned subsidiary Bespak are the makers of the company's low-cost, proprietary multi-plex cartridges ...
PR Newswire
5/1/2019 binx health Receives CE Mark For Rapid Chlamydia And Gonorrhea Test For Mass Markets
... care and at home offerings. binx health's investors include financial investors, Johnson & Johnson Innovation, Novartis Venture Fund, LSP Venture Capital, BB Biotech, RMI Investments and Technology Venture Partners and strategic investors, Consort Medical (whose wholly owned subsidiary Bespak are the makers of the company's low-cost, proprietary multi-plex cartridges ...
PR Newswire